Broader use of new MDR-TB drugs in treatment settings would bring immediate benefits to patients, Dr. KJ Seung of PIH and Dr. Cathy Hewison of MSF write in The Lancet Global Health this week.
PIH researchers, clinicians helped lead study that again showed new-generation TB drugs to be more effective, including for patients with additional diseases.
PIH’s systems strengthening over the years has paved the way for a quick and comprehensive response to COVID-19 in Peru, even as the country scrambles for resources to stave off a stubborn pandemic and an alarming surge of cases.
The expansion will greatly improve Pleebo's capacity to meet emergency needs and provide care in areas ranging from hypertension and diabetes to maternal and child health.
Earth Day and COVID-19 are powerful reminders that social justice issues are interdependent and require global collaboration.
Lessons can be drawn from the treatment of TB, the world's deadliest infectious disease, to confronting COVID-19.
Dedicated care and new treatments have helped the Moleko family move from despair to hope in their multi-generational battles with TB.
Rapid tests are a key part of PIH's "unprecedented response" to COVID-19, amid challenges of testing in countries with minimal lab resources.
19 snapshots of how PIH brings justice to health care around the world
Join the infectious disease expert and PIH co-founder in Sierra Leone as he mentors clinicians through their most difficult cases.